Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 1 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Farma Jonkers from Balen, company number BE0834527820, closed financial year 2025 with a result of € 546,861 after tax. For that financial year Farma Jonkers recorded a gross margin of € 143,646 and equity of € 1.7 million. Compared with financial year 2024, the result moved from € 117,696 to € 546,861. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.
€ 1.7 million
▲ 46% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 546,861
▲ € 429,165 vs 2024
Profit after tax over the fiscal year.
€ 3,281
▲ 43% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 1.7 million.
Debts at end 2025
€ 47,540
▼ 76% vs 2024
Loans from banks and other lenders, long and short.
€ 772
▲ 34% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 11,276
▼ 6% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 144,956 | € 153,167 | € 166,197 | € 143,646 | ▼ 14% |
| Profit after taxes | € 96,695 | € 98,381 | € 117,696 | € 546,861 | ▲ € 429,165 |
| Equity | € 976,296 | € 1,066,677 | € 1,176,372 | € 1,723,233 | ▲ 46% |
| Total debts | € 1,076,378 | € 985,873 | € 876,868 | € 330,998 | ▼ 62% |
| Cash | € 2,714 | € 2,431 | € 2,292 | € 3,281 | ▲ 43% |
| Retained profit | € 957,696 | € 1,048,077 | € 1,157,772 | € 1,704,633 | ▲ 47% |
| Dividend | € 8,000 | € 8,000 | € 8,000 | € 0 | ▼ 100% |
| Bank debt | € 471,586 | € 334,485 | € 197,191 | € 47,540 | ▼ 76% |
| Balance sheet total | € 2,052,674 | € 2,052,549 | € 2,053,240 | € 2,054,231 |
Key figures of Farma Jonkers, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Farma Jonkers?
What happened at Farma Jonkers in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 546,861 (▲ € 429,165 vs 2024). filed late Source: NBB ↗
- New establishment in Balen. KBO
- Ilse Jonkers became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 96,695 profit in 2022 to € 546,861 profit in 2025.
Paid € 107,215 in corporate taxes since 2022.
Best year ever: 2025, with € 546,861 profit.
Paid out € 24,000 in dividends to the owners in total.
Management
Behind Farma Jonkers is Ilse Jonkers. It owns 100% of Apotheek Jonkers Ilse BV itself.
Directors
According to the 2025 annual accounts
Ilse Jonkers
Director
since 2011
Establishments
Establishment units
Physical locations of this company
Markt 30
2490 Balen
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0834.527.820
- VAT number
- BE 0834.527.820
- Registered office
- Markt 30, 2490 Balen
- Names & denominations
- Farma Jonkers
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 14 March 2011
- Peppol
- Active · Active since 26 Nov 2025
- Activities · NACE
Activiteiten van holdings
Holdings